Suppr超能文献

新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)的作用机制研究。肌膜和细胞内细胞器的酶活性及Ca2+转运过程。

Studies on the mechanism of action of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), a new positive inotropic drug. Enzyme activities and Ca2+ transport processes of sarcolemma and intracellular organelles.

作者信息

Schwartz A, Wallick E T, Lee S W, Wang T, Hosakawa T, Whitmer K R, Matlib M A

出版信息

Arzneimittelforschung. 1984;34(3A):384-9.

PMID:6540093
Abstract

3,4-Dihydro-6-[4-(3,4- dimethoxybenzoyl )-piperazinyl]-2(1H)- quin olinone ( OPC -8212) is a new positive inotropic agent. In studies designed to elucidate information concerning its mechanism of action, its effect on Ca+ transport and related enzyme activities in sarcolemma, sarcoplasmic reticulum and mitochondria were studied. OPC -8212 was found to have little or no effect on these processes. The mechanism of action therefore is clearly different from other known positive inotropic drugs.

摘要

3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-哌嗪基]-2(1H)-喹啉酮(OPC-8212)是一种新型正性肌力药。在旨在阐明其作用机制相关信息的研究中,研究了它对肌膜、肌浆网和线粒体中Ca+转运及相关酶活性的影响。结果发现OPC-8212对这些过程几乎没有影响。因此,其作用机制明显不同于其他已知的正性肌力药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验